| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer
1 company
Gwenn Hansen is Chief Scientific Officer at NRIX. From November 2020 to November 2026, the filings on record show 0 open-market purchases and 40 sales. Gwenn Hansen's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $3.2M at current prices.
Historically, Gwenn Hansen's trades have earned a strong insider score of 70/100 across 35 rated trades. Over a 12-month horizon, 78.6% of those trades were profitable, with an average 12-month return of +22.1%.
The NRIX filings lean toward selling, a net 80,920 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 1, 2021 | NRIX Nurix Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 400 | $32.34 | $12,936.00 | -2.7% | -9.8% | -48.7% | |
| Aug 2, 2021 | NRIX Nurix Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 400 | $31.21 | $12,484.00 | -2.8% | +8.1% | -48.1% | |
| Jul 1, 2021 | NRIX Nurix Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 400 | $26.76 | $10,704.00 | -2.8% | +6.8% | -51.7% | |
| Jun 1, 2021 | NRIX Nurix Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 400 | $27.74 | $11,096.00 | -2.8% | +16.9% | -66.6% | |
| May 3, 2021 | NRIX Nurix Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 800 | $35.00 | $27,996.00 | -5.5% | -5.3% | -66.7% | |
| Apr 5, 2021 | NRIX Nurix Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 400 | $35.00 | $14,000.00 | -2.8% | -33.1% | -59.7% | |
| Apr 1, 2021 | NRIX Nurix Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 400 | $31.55 | $12,620.00 | -2.8% | -14.5% | -55.0% | |
| Mar 16, 2021 | NRIX Nurix Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 800 | $45.00 | $36,000.00 | -5.5% | -34.9% | -69.3% | |
| Mar 1, 2021 | NRIX Nurix Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 800 | $35.95 | $28,760.00 | -5.5% | - | - | |
| Feb 18, 2021 | NRIX Nurix Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 800 | $36.27 | $29,018.02 | -6.3% | - | - |